Free Trial
OTCMKTS:WLCGF

Welcia 7/8/2025 Earnings Report

$16.41 0.00 (0.00%)
As of 08/29/2025

Welcia EPS Results

Actual EPS
$0.20
Consensus EPS
$0.13
Beat/Miss
Beat by +$0.07
One Year Ago EPS
N/A

Welcia Revenue Results

Actual Revenue
$2.32 billion
Expected Revenue
$2.30 billion
Beat/Miss
Beat by +$17.99 million
YoY Revenue Growth
N/A

Welcia Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Welcia's next earnings date is estimated for Wednesday, October 8, 2025, based on past reporting schedules.

Conference Call Resources

Welcia Earnings Headlines

New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.tc pixel
See More Welcia Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Welcia? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Welcia and other key companies, straight to your email.

About Welcia

Welcia (OTCMKTS:WLCGF) Co., Ltd., operating under the Welcia brand, is one of Japan’s foremost pharmacy and drugstore chains. Headquartered in Saitama Prefecture, the company specializes in the retail sale of prescription medications, over-the-counter drugs, cosmetics, health and wellness products, and daily consumer goods. Welcia’s outlets combine pharmaceutical services with a wide selection of personal care and household items to meet the needs of local communities.

Founded in 1974, Welcia has expanded through a mix of new store openings and strategic acquisitions, building a network of over 2,000 locations across Japan. The company places a strong emphasis on its in-store pharmacies, where licensed pharmacists handle prescription dispensing, offer medication guidance and conduct basic health consultations. This focus on professional healthcare services supports Welcia’s goal of enhancing customer well-being.

In response to evolving consumer preferences, Welcia has developed an omnichannel strategy that includes online ordering, home delivery of prescriptions and health products, and digital tools for prescription refills. These initiatives are designed to improve convenience, foster customer loyalty and integrate physical and digital touchpoints. The company also invests in pharmacy technology and staff training to maintain high standards of patient care.

Welcia is listed on the Tokyo Stock Exchange and operates under the broader Welcia Holdings corporate framework. While its primary market remains within Japan, the company continues to focus on optimizing its domestic network and exploring service enhancements that reinforce its position in the competitive retail pharmacy sector.

View Welcia Profile

More Earnings Resources from MarketBeat